IPHA
Innate Pharma

1,492
Mkt Cap
$151.83M
Volume
29,957.00
52W High
$2.63
52W Low
$1.57
PE Ratio
-2.71
IPHA Fundamentals
Price
$1.62
Prev Close
$1.69
Open
$1.70
50D MA
$1.77
Beta
0.39
Avg. Volume
20,332.50
EPS (Annual)
-$0.6602
P/B
24.73
Rev/Employee
$75,431.50
$97.59
Loading...
Loading...
News
all
press releases
Number of Shares and Voting Rights of Innate Pharma as of February 19, 2026
Regulatory News: Pursuant to the article L. 233-8 II of the French Code de Commerce and the article 223-16 of the French stock-market authorities (Autorit des Marchs Financiers, or AMF) General...
Business Wire·3d ago
News Placeholder
More News
News Placeholder
Innate Pharma to Participate in the Leerink Partners Global Healthcare Conference
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (Innate or the Company), a clinical-stage biotechnology company developing immunotherapies for cancer patients, today announced...
Business Wire·4d ago
News Placeholder
Innate Pharma (NASDAQ:IPHA) Stock Price Down 2.2% - Should You Sell?
Innate Pharma (NASDAQ:IPHA) Shares Down 2.2% - Should You Sell...
MarketBeat·18d ago
News Placeholder
Innate Pharma (NASDAQ:IPHA) Shares Up 2.3% - Should You Buy?
Innate Pharma (NASDAQ:IPHA) Trading Up 2.3% - Time to Buy...
MarketBeat·2mo ago
News Placeholder
Number of Shares and Voting Rights of Innate Pharma as of December 18, 2025
Regulatory News: Pursuant to the article L. 233-8 II of the French Code de Commerce and the article 223-16 of the French stock-market authorities (Autorit des Marchs Financiers, or AMF) General...
Business Wire·2mo ago
News Placeholder
Innate Pharma (OTCMKTS:IPHYF) Stock Price Up 13.1% - Time to Buy?
Innate Pharma (OTCMKTS:IPHYF) Trading 13.1% Higher - Time to Buy...
MarketBeat·2mo ago
News Placeholder
Innate Pharma Releases Its 2026 Financial Calendar
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (Innate or the Company) today released its 2026 financial calendar: March 26, 2026: Publication of 2025 financial statements May...
Business Wire·2mo ago
News Placeholder
Innate Pharma (OTCMKTS:IPHYF) Shares Down 0.2% - Time to Sell?
Innate Pharma (OTCMKTS:IPHYF) Shares Down 0.2% - Here's Why...
MarketBeat·3mo ago
News Placeholder
Innate Pharma (NASDAQ:IPHA) Stock Price Up 3.7% - Should You Buy?
Innate Pharma (NASDAQ:IPHA) Trading 3.7% Higher - Here's Why...
MarketBeat·3mo ago
News Placeholder
Number of Shares and Voting Rights of Innate Pharma as of November 27, 2025
Regulatory News: Pursuant to the article L. 233-8 II of the French Code de Commerce and the article 223-16 of the French stock-market authorities (Autorit des Marchs Financiers, or AMF) General...
Business Wire·3mo ago
<
1
2
...
>

Latest IPHA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.